Free Republic

An international group of researchers believe there is enough evidence that anti-malarial drugs could be repurposed to treat COVID-19 and that they should be assessed for efficacy in clinical trials. The review article, published online in Trends in Parasitology, outlines the evidence for the antiviral and anti-inflammatory properties of certain anti-malarial drugs that could play a role in tackling COVID-19. The research group, from institutions across Europe, Asia and Africa, point to a combination of the drugs artesunate and pyronaridine as the most promising. Both drugs have demonstrated antiviral effects on the SARS-CoV-2 virus in human lung cells in laboratory...

Doctor, former Kansas governor says coronavirus patients 'doing better' in testing with anti-malaria drug Dr. Jeff Colyer on the effectiveness of hydroxychloroquine to treat COVID-19 President Trump calls the malaria drug hydroxychloroquine a ‘game changer’ in treating the coronavirus; reaction and analysis from former Kansas governor, practicing surgeon Dr. Jeff Colyer. Anti-malaria drugs ike hydroxychloroquine -- which are being used to treat coronavirus (COVID-19) patients -- are showing positive results, former Kansas governor and practicing surgeon Dr. Jeff Colyer said Wednesday. Appearing on "America's Newsroom" with host Ed Henry, Colyer said that data from testing at the University of Kansas...

WASHINGTON, May 26 (UPI) -- Six U.S. soldiers have been diagnosed by the military with permanent brain damage from an anti-malaria drug used in Iraq and Afghanistan, and health officials must reassess its safety, a U.S. senator said. Sen. Dianne Feinstein, D-Calif., in a letter to Health and Human Services Secretary Tommy Thompson, said the drug, called mefloquine, has "serious risks" that have not been adequately tracked by the Pentagon, the Peace Corps and other government agencies that distribute it. "I ask that you work with the Food and Drug Administration to reassess the safety of mefloquine," Feinstein wrote Thompson...